clinical trial · NCT06084598
A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986446 in Healthy Participants and Healthy Participants of Japanese Ethnicity
Bristol-Myers Squibb·phase1·completed·n = 24
Healthy ParticipantsBMS-986446Placebo
brief summary
The purpose of this study is to evaluate the safety, tolerability and drug levels of BMS-986446 in healthy participants including healthy participants of Japanese ethnicity.
started
Oct 12, 2023
primary completion
Mar 8, 2024
completion
Mar 8, 2024
last updated
Mar 15, 2024
official title
A Randomized, Double-blind, Placebo-controlled, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravenously Administered BMS-986446 in Healthy Participants Including Healthy Participants of Japanese Ethnicity
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol